Výsledky vyhledávání - "Hans Peterse"

Akademický článek

Racial and Ethnic Minorities Have a Lower Prevalence of Airflow Obstruction than Non-Hispanic Whites

Autor: Akshay Sood, Hans Petersen, Congjian Liu, Orrin Myers, Xin Wang Shore, Bobbi A. Gore, Rodrigo Vazquez-Guillamet, Linda S. Cook, Paula Meek, Yohannes Tesfaigzi

Publikováno v: COPD, Vol 19, Iss 1, Pp 61-68 (2022)

Racial and ethnic disparities in chronic obstructive pulmonary disease (COPD) are not well-studied. Our objective was to examine differences in limited COPD-related outcomes between three minority groups—African Americans (AAs), Hispanics, and Amer

Externí odkaz: https://doaj.org/article/3b824d1230f84d3ca46ae34af902af5f

Zobrazit plný text záznamu

Plný text ve formátu HTML

BRCA1-associated breast cancers present differently from BRCA2-associated and familial cases: long-term follow-up of the Dutch MRISC Screening Study

Publikováno v: Journal of Clinical Oncology, 28(36), 5265-5273
Rijnsburger, A J, Obdeijn, I M, Kaas, R, Tilanus-Linthorst, M M, Boetes, C, Loo, C E, Wasser, M N, Bergers, E, Kok, T, Muller, S H, Peterse, H, Tollenaar, R A, Hoogerbrugge, N, Meijer, S, Bartels, C C, Seynaeve, C, Hooning, M J, Kriege, M, Schmitz, P I, Oosterwijk, J C, Koning, H J, Rutgers, E J & Klijn, JG 2010, ' BRCA1-associated breast cancers present differently from BRCA2-associated and familial cases: long-term follow-up of the Dutch MRISC Screening Study ', Journal of Clinical Oncology, vol. 28, no. 36, pp. 5265-5273 . https://doi.org/10.1200/JCO.2009.27.2294
Journal of Clinical Oncology, 28, 5265-73
Journal of Clinical Oncology, 28(36), 5265-5273. AMER SOC CLINICAL ONCOLOGY
Journal of clinical oncology, 28(36), 5265-5273. American Society of Clinical Oncology
Journal of Clinical Oncology, 28, 36, pp. 5265-73
Journal of Clinical Oncology, 28(36), 5265-5273. American Society of Clinical Oncology

Purpose The Dutch MRI Screening Study on early detection of hereditary breast cancer started in 1999. We evaluated the long-term results including separate analyses of BRCA1 and BRCA2 mutation carriers and first results on survival. Patients and Meth

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c382bc2e842671d2251cac6dec54f92d
https://hdl.handle.net/2066/88479

Zobrazit plný text záznamu

Genetic and Phenotypic Characteristics of Pleomorphic Lobular Carcinoma In Situ of the Breast

Autor: Patrick L. Fitzgibbons, Joseph M. Anderson, Sandy DeVries, Eun-Sil Shelley Hwang, Ritu Roy, Yunn-Yi Chen, Taku Tokuyasu, Anne Vincent-Salomon, Gaëtan MacGrogan, Stuart J. Schnitt, Frederic M. Waldman, Chrystal V. Wa, Timothy W. Jacobs, Hans Peterse

Publikováno v: American Journal of Surgical Pathology. 33:1683-1694

The clinical, pathologic, and molecular features of pleomorphic lobular carcinoma in situ (PLCIS) and the relationship of PLCIS to classic LCIS (CLCIS) are poorly defined. In this study, we analyzed 31 cases of PLCIS (13 apocrine and 18 nonapocrine s

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::96046ca7c6e968246e82bb2ca6504570
https://doi.org/10.1097/pas.0b013e3181b18a89

Zobrazit plný text záznamu

Continuing risk of ipsilateral breast relapse after breast-conserving therapy at long-term follow-up

Autor: Augustinus A. M. Hart, Tony van de Velde, Emiel J. Th. Rutgers, Jacques Borger, Marc J. van de Vijver, Hans Peterse, Harry Bartelink, Bas Kreike

Publikováno v: International journal of radiation oncology, biology, physics, 71(4), 1014-1021. Elsevier Inc.

Purpose Currently, the local treatment of most patients with early invasive breast cancer consists of breast-conserving therapy (BCT). We have previously reported on the risk factors for ipsilateral breast relapse (IBR) in 1,026 patients treated with

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::88b458f0acf4234a18c753a74395ea2c
https://doi.org/10.1016/j.ijrobp.2007.11.029

Zobrazit plný text záznamu

Tumor characteristics and detection method in the MRISC screening program for the early detection of hereditary breast cancer

Publikováno v: Breast cancer research and treatment, 102(3), 357-363. Springer New York
Breast Cancer Research and Treatment, 102(3), 357-363. Springer New York
Breast Cancer Research and Treatment, 102, 357-63
Breast Cancer Research and Treatment, 102(3), 357-363. SPRINGER
Breast Cancer Research and Treatment, 102, 3, pp. 357-63

In the MRISC study, women with an inherited risk for breast cancer were screened by a 6-month clinical breast examination (CBE) and yearly MRI and mammography. We found that the MRISC screening scheme could facilitate early breast cancer diagnosis an

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bfd783fc8191dfdcdc6e57c135bc50f5
https://doi.org/10.1007/s10549-006-9341-6

Zobrazit plný text záznamu

Gene Expression Profiling in Breast Cancer: Understanding the Molecular Basis of Histologic Grade To Improve Prognosis

Publikováno v: JNCI: Journal of the National Cancer Institute. 98:262-272

Background: Histologic grade in breast cancer provides clinically important prognostic information. However, 30% – 60% of tumors are classifi ed as histologic grade 2. This grade is associated with an intermediate risk of recurrence and is thus not

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::95a1a8ca4a0ef9bb60691889ce05e29a
https://doi.org/10.1093/jnci/djj052

Zobrazit plný text záznamu

Hereditary breast cancer growth rates and its impact on screening policy

Autor: Alexander M.M. Eggermont, Mieke Kriege, Harry J. de Koning, H. M. Zonderland, Hans Peterse, Jan C. Oosterwijk, Sybren L. Meijer, Madeleine M.A. Tilanus-Linthorst, Cecile T. M. Brekelmans, Wim C. J. Hop, Inge-Marie Obdeijn, Carla Boetes, Jan G. M. Klijn

Publikováno v: European Journal of Cancer, 41, 11, pp. 1610-7
European Journal of Cancer, 41(11), 1610-1617. ELSEVIER SCI LTD
European Journal of Cancer, 41(11), 1610-1617. Pergamon
European Journal of Cancer, 41(11), 1610-1617. Elsevier Ltd.
Tilanus-Linthorst, M M, Kriege, M, Boetes, C, Hop, W C, Obdeijn, I M, Oosterwijk, J C, Peterse, H L, Zonderland, H M, Meijer, S, Eggermont, AM, Koning, H J & Klijn, JG 2005, ' Hereditary breast cancer growth rates and its impact on screening policy ', European Journal of Cancer, vol. 41, no. 11, pp. 1610-1617 . https://doi.org/10.1016/j.ejca.2005.02.034
European Journal of Cancer, 41, 1610-7

Contains fulltext : 47763.pdf (Publisher’s version ) (Closed access) Imaging is often performed yearly for the surveillance of BRCA1/2 mutation carriers and women at high familial breast cancer risk. Growth of cancers in carriers may be faster as t

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f57dc6e0ef7659cdc64b8246cae6c079
https://doi.org/10.1016/j.ejca.2005.02.034

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání